Current location - Plastic Surgery and Aesthetics Network - Plastic surgery and medical aesthetics - What leading stocks are there in the medical industry in 2023?
What leading stocks are there in the medical industry in 2023?
What leading stocks are there in the medical industry in 2023?

Drugs are substances or preparations used to prevent, treat or diagnose human and livestock diseases. Medicine can prevent diseases, treat diseases, relieve pain, improve health, or enhance the body's resistance to diseases or help diagnose diseases. So what leading stocks are there in the medical industry? Let's take a look at the related content analysis! I hope it will help everyone!

What leading stocks are there in the medical industry?

1, Hengrui Pharma (600276) China Company, the domestic chemical pharmaceutical strength is the first, and it has the best opportunity to challenge the international pharmaceutical giants;

2. Yunnan Baiyao (000538) is the first brand of traditional Chinese medicine and the first brand of domestic toothpaste;

3. Wuxi PharmaTech (603259) is the world's leading "integrated, end-to-end" new drug research and development service platform;

4. The recombinant human insulin products owned by tonghua dongbao (600867) filled the domestic blank;

5. Well-known R&D enterprise Kelun Pharmaceutical (002422) infusion series drugs;

6. Xinhecheng (00200 1) is the largest manufacturer of vitamin A and vitamin E in China;

7. Hualan Bio (002007) is a leading enterprise in the domestic blood products and vaccine products industry;

8. The leading products of Changchun Hi-Tech (00066 1) are growth hormone series products and freeze-dried live attenuated varicella vaccine, with obvious market advantages;

9. Hua En Pharmaceutical (002262) is mainly engaged in the research and development of central nervous system drugs and cardiovascular and cerebrovascular drugs;

10, Aier Ophthalmology (3000 15) is one of the largest ophthalmic medical institutions in China and a leading chain enterprise of private ophthalmic hospitals.

What leading stocks are there in the medical industry?

Candley (603987)

As a leading enterprise in the field of medical puncture devices in China, Shanghai Kangdeli Enterprise Development Group Co., Ltd. has been focusing on providing medical products and services in the fields of medical puncture devices, medical polymer consumables, interventional consumables, medical device market supply chain and so on for domestic and foreign customers under the guidance of the quality policy of "building KDL brand and winning the trust of hundreds of millions of users". The company has been rated as "Top 100 Manufacturing Enterprises in Shanghai" by Shanghai for many years, and its products have successively won the titles of "Shanghai Famous Brand Product", "Shanghai Famous Trademark" and excellent brand products of national trade associations.

Sanxin Medical Treatment (300453)

Jiangxi Sanxin Medical Technology Co., Ltd. is a national high-tech enterprise specializing in research and development, manufacture, sales and service of medical devices. Founded in 1997, the company has grown into a listed company in the infusion field in China after more than 20 years of accumulation.

Meinian Health (002044)

Founded in 2004, Meinianda Health Industry Holding Co., Ltd. is a well-known professional health examination and medical service group in China. Professional health services have been provided to 20 million people in 17, and will be provided to more than 30 million people in 18. The Group successfully listed on the A-share market in August of 15, and acquired "Zhao Mei" and "Ciming" in June of 16 and June of 17, respectively, becoming listed companies with outstanding market value and influence in the medical and general health fields.

Zhende Medical (60330 1)

Zhende Medical Products Co., Ltd. is a leading enterprise integrating R&D, production and sales. The group involves traditional medical dressings, pressure therapy and fixation, modern wound care, surgical infection management, incontinence care products, automation equipment and other industries.

Xingpu Medical Department (300 143)

Yingkang Life Science and Technology Co., Ltd. was established in 1998 and listed on the Growth Enterprise Market of Shenzhen Stock Exchange on 10 and 12 with the stock code of 300 143. Based on the manufacture of large-scale radiotherapy equipment gamma knife and proton therapy system, the company gives full play to the advantages of high-end radiotherapy equipment and continuously expands its business in the medical and health field, forming a development pattern of providing high-end large-scale radiotherapy equipment and supporting solutions and providing medical and health services.

What leading stocks are there in the medical industry?

Lan Yan holding 00968

The main business of Shanxi Lan Yan Holding Co., Ltd. is coal mine gas control and coalbed methane exploration, development and utilization. The leading products are coalbed methane (coal mine gas) and so on. The company cooperated with China University of Mining and Technology, Xi Branch of Coal Science Research Institute and other scientific research institutions to build the Industry-University-Research base of coalbed methane development project, set up the development and utilization engineering technology research center, and established the first comprehensive gas control demonstration base in China. There are more than 100 core technologies with international leading level in the development and utilization of coalbed methane, and 60 national patents (including 52 invention patents) have been applied for and won, and scientific research achievements have won 3 national science and technology progress awards, 26 science and technology awards of coal industry association, 5 science and technology awards of State Administration of Work Safety and 5 science and technology awards of Shanxi Province.

Luan Huaneng 60 1699

The main business of Shanxi Luan Environmental Protection Energy Development Co., Ltd. includes raw coal mining, coal washing and coking; Development and utilization of clean coal technology; Coalbed methane development; Comprehensive utilization of coal and geological exploration, etc. The main types of coal mined by the company are lean coal, lean coal and lean coal. Coal products belong to high-quality power coal and coking coal blending with ultra-low sulfur, low phosphorus, low ash and high calorific value, mainly including coal blending, clean coal, coal injection and block washing, and coke products, which are mainly used in power generation, electric power, coking and steel industries. In terms of industrial development, relying on the nearly 60 years' development and industry experience accumulation of controlling shareholder Lu 'an Group, the company's intensive and efficient production level, technical equipment level, scientific and technological research and development strength and safety management level all rank in the forefront of the whole coal industry.

Orchidaceae Chuang 600 123

Shanxi Orchid Technology Venture Co., Ltd. is mainly engaged in the production and sales of coal, fertilizer and building materials. The company's main products are anthracite, coking coal, power coal, urea, dimethyl ether and caprolactam. The development of the company's coal mine virtual reality training system has reached the international advanced level, and the project won the third prize of the Science and Technology Award of China Coal Industry Association 19.

Panjiang stock 600395

Guizhou Panjiang Clean Coal Co., Ltd. is mainly engaged in coal mining, washing, processing and sales, as well as the production and sales of electricity. The main products are coal and electricity. As the largest coal producer in Southwest China, the company undertakes the task of coal supply in Southwest China. Guizhou province is rich in coal resources, known as the southern coal sea, second only to Mongolia, Shanxi, Xinjiang and Shaanxi, ranking fifth in the country. Panjiang mining area, where the company is located, is listed as one of the top ten mining areas for key development by the state, and is the largest coking coal enterprise in southwest China.

China Coal Energy 60 1898

The main business of China China Coal Energy Co., Ltd. is coal production and trade, coal chemical industry, coal mine equipment manufacturing, pit power generation, finance and related services. The main products are power coal, coking coal, polyolefin, urea, methanol and so on. The company's main coal industry has outstanding advantages in scale, leading in coal mining, washing and coal blending technology, and the production cost of coal mines is lower than that of most domestic coal enterprises. The company is rich in coal resources. Shanxi Pingshuo Mining Area and Inner Mongolia Erdos Hugellert Mining Area are important thermal coal production bases in China. Coking coal resources in Xiangning mining area of Shanxi Province are high-quality coking coal resources with low sulfur and ultra-low phosphorus in China. 18 after the acquisition of SDIC Jincheng energy investment co., ltd, anthracite resources increased by 320 million tons. At the same time, the company's key coal construction projects made positive progress. Mudu Chaideng Coal Mine and Nalinhe No.2 Coal Mine have been put into production, Xiaohuigou Coal Mine has the conditions for joint trial operation, and projects such as Dahai Coal Mine and Bi Li Coal Mine have been steadily advanced.

What leading stocks are there in the medical industry?

Jinhao medical treatment 872925

Huizhou Jinhao Medical Technology Co., Ltd. is mainly engaged in research and development, production and sales of rehabilitation medical devices and household medical devices. The main products include hearing AIDS, atomizers and bedsore-preventing air cushions.

The company's products mainly provide hearing assistance, respiratory disease treatment, health care and other functions for individual consumers and families, helping consumers to improve disease symptoms, prevent diseases and improve their quality of life. The company mainly sells overseas, and its export areas cover more than 90 countries and regions around the world such as Europe, Asia and America. Customers include well-known enterprises such as Sivanto in Germany, Green Oak in Japan and Borle in Germany.

Xiangsheng medical treatment 688358

The main business of Wuxi Xiangsheng Medical Technology Co., Ltd. is the research and development, manufacture and sales of ultrasonic medical imaging equipment. The company's main products include portable color Doppler ultrasound, cart color Doppler ultrasound and black-and-white ultrasound. The company's products have covered more than 30% of tertiary hospitals, including the well-known Peking Union Medical College Hospital, Huaxi Hospital and Shanghai Sixth People's Hospital.

Products are widely used in ultrasound, anesthesia, catheter and other departments of the above hospitals. In addition, it occupies a leading position in the service evaluation of primary medical institutions in China.

Ruiang gene 6882 17

The main business of Shanghai Ruiang Gene Technology Co., Ltd. is the research and development, production, sales and scientific research services of in vitro diagnostic products; The company's main products are molecular diagnostic reagents. The company has 90 medical device products approved by the State Administration of Pharmaceutical Products or put on record by the drug supervision and administration department, including 28 registered products of the third category, 2 registered products 1 and 6 registered products of the first category1.

The leukemia molecular diagnostic kit independently developed by the company is the first product of its kind in China to obtain the third-class medical device registration certificate of the State Medical Products Administration, which is suitable for the whole process of leukemia diagnosis. Three kinds of solid tumor molecular diagnostic kits are the first products in China to obtain the registration certificate of three kinds of medical devices from the State Medical Products Administration. The molecular diagnostic kit for various infectious diseases is the first or only product in China that has obtained the third class medical device registration certificate from the National Medical Products Administration.

Kangtuo Medical 6883 14

The main business of Xi Ankang Tuo Medical Technology Co., Ltd. is the research and development, production and sales of three types of implantable medical devices. The company's main products include titanium skull repair and fixation products and PEEK skull repair and fixation products for neurosurgery implantation, as well as sternum fixation products, neurospinal products, supporting implantation tools and other products.

The company occupies the largest market share in the market of PEEK skull repair and fixation products, and it is one of the few enterprises in China that can provide diversified solutions for skull repair and fixation in neurosurgery around the needs of patients. The company was awarded the second prize of national technological invention by the State Council in 14.

What leading stocks are there in the medical industry?

Aimeike (sz300896)

The company is an innovative leading enterprise in the field of biomedical soft tissue repair materials in China. Based on the research and transformation of biomedical materials, the company is committed to the development of biomedical materials such as recombinant proteins and peptides. Successfully realized the industrialization of sodium hyaluronate series products for injection and poly (p-dioxanone) facial implant line, and established a technical transformation platform for biomedical materials such as medical chitosan and polylactic acid. The clinical application of the product covers medical beauty, surgical repair and treatment of metabolic diseases.

Huitai Medical (sh6886 17)

The company is a high-tech enterprise specializing in R&D, electrophysiology and interventional medical devices production and sales, and has formed a business layout with complete coronary artery access and electrophysiology medical devices as the leading factor and peripheral vascular and nerve interventional medical devices as the key development direction. The company is one of the enterprises with complete varieties, leading scale and strong market competitiveness of electrophysiological and vascular interventional medical devices in China, and one of the few enterprises that can form strong competition with foreign products.

Mindray Medical Treatment (sz300760)

The company is mainly engaged in the research and development, manufacturing, marketing and service of medical devices, always oriented to customer needs, and committed to providing quality products and services to medical institutions around the world. The company integrates innovation, closely meets clinical needs and supports medical institutions to provide high-quality medical services, thus helping to improve medical conditions and reduce global medical costs.

Yirui technology (sh68830 1)

The company is a digital X-ray detector manufacturer oriented by the technical development trend of the whole industry chain, and its technical level is in line with international standards. Mainly engaged in the research and development, production, sales and service of digital X-ray detectors, products are widely used in medical diagnosis and treatment, industrial nondestructive testing, security inspection and other fields.

Jardine Ye Jia (sz30 1367)

The company is a leading manufacturer of medical equipment and consumables in the field of respiratory health in China. Its main products include home non-invasive ventilators, ventilators, sleep monitors, large-flow humidified oxygen therapeutic devices, and provide respiratory health and chronic disease management services. The company continues to develop a full range of medical products around the field of respiratory health, and the product line layout is relatively perfect. The platform construction covering household, medical care, consumables and chronic disease management in this field has been initially completed, and there is obvious synergy between products, which meets patients' full-cycle, multi-scenario and systematic health needs.